Intravenous (iv) infusion of the angiotensin II (ANG II) receptor blocker s
aralasin in resting conscious dogs during physiological pertubations, such
as hypotension and prolonged hypoxia, indicates the presence of an ANG II d
rive to increase respiration and decrease the arterial partial pressure of
CO2 (Pa-CO2). In contrast, in eupneic resting dogs on a regular chow diet,
iv infusion of saralasin for short periods (up to 30 min) provides no evide
nce of a tonic effect of circulating levels of ANG II on acid-base balance,
respiration, metabolism, or circulation. However, ANG II influences physio
logical processes involving salt, water, and acid-base balances, which are
potentially expressed beyond a 30 min time period, and could secondarily af
fect respiration. Therefore, we tested the hypothesis that blocking ANG II
with iv saralasin would affect respiration and circulation over a 4-h perio
d. Contrary to the hypothesis, iv infusion of saralasin in resting consciou
s eupneic dogs on a regular chow diet over a 4-h period had no effects on p
lasma strong ions, osmolality, acid-base balance, respiration, metabolism,
or circulation when compared with similar control studies in the same anima
ls. Thus, ANG II does not play a tonic modulatory role in respiratory contr
ol under "normal" physiological conditions.